NSEInvestor Presentation4d ago · 5 Nov 2026, 10:05 pm

Investor Presentation

Godavari Biorefineries Limited · GODAVARIB

✦ AI Summary▲ PositiveResults

Godavari Biorefineries Limited has informed the Exchange about Investor Presentation for the quarter and half year ended September 30, 2026, with highlights of consolidated Q2 & H1 FY27 performance, revenue mix, and consolidated P&L statement.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Godavari Biorefineries Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

GODAVARIBIO_05112026220534_Intimation_to_SE.pdf

pdf

Download →
View document text
Dated: November 5, 2026 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Tower, Bandra Kurla Complex, Bandra (E), Dalal Street Mumbai – 400 051 Mumbai-400001 Script Symbol: GODAVARIB Script Code:544279 Dear Sir / Madam, Sub: INVESTOR PRESENTATION Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation for the quarter and half year ended September 30, 2026 This is for your information and records. Thanking you, Yours faithfully For Godavari Biorefineries Limited Manoj Jain Company Secretary & Compliance O(cid:431)icer Membership No. F-7998 Godavari Biorefineries Limited Investor Presentation | Q2 & H1 FY27 CREATING a Beautiful World With Innovation at the Core, Unified in Growth, Sustainability & Inclusivity. Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Godavari Biorefineries Limited (the “Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company's future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cashflows, the Company's market preferences and its exposure to market risks, as well as other risks. The Company's actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections. All Maps used in the presentation are not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness. Godavari Biorefineries Limited 2 Q2 & H1 FY27 Highlights Consolidated Q2 & H1 FY27 Performance Q2 FY27 | QUARTERLY PERFORMANCE H1 FY27 | HALF-YEAR PERFORMANCE TOTAL REVENUE Q2 FY27 | QUEABRITTDERALY PERFORMANCE EBITDA MARGIN TOTAL REVENUEH1 FY27 | HALF-Y EEA BR IT P DE ARFORMANCE EBITDA MARGIN 549.8 10.9 2.0 % 1109.7 13.4 1.2% 968.2 434.4 2.1 0.2% Q2 FY26 Q2 FY27 (4.4) (1.0)% H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 +27% YoY Turned +ve Turned +ve +15% YoY +543% YoY +99 bps Godavari Biorefineries Limited 4 Bio-based Chemicals Segment Q2 FY27 | QUARTERLY PERFORMANCE H1 FY27 | HALF-YEAR PERFORMANCE TOTAL REVENUE EBITDA EBITDA MARGIN TOTAL REVENUE EBITDA EBITDA MARGIN 204.2 22.1 10.8 % 372.9 41.2 11.1% 10.2 % 9.6% 288.3 147.1 15.0 27.6 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 +39% YoY +47% YoY +60 bps +29% YoY +50% YoY +150 bps The segment’s performance was supported by ongoing debottlenecking initiatives and improved operational efficiencies, driving higher revenue and EBITDA growth alongside an improvement in margins during the first half of FY27. Godavari Biorefineries Limited 5 Integrated Sugar, Co-generation & Ethanol Segment Q2 FY27 | QUARTERLY PERFORMANCE H1 FY27 | HALF-YEAR PERFORMANCE TOTAL REVENUE EBITDA EBITDA MARGIN TOTAL REVENUE EBITDA EBITDA MARGIN 334.2 712.1 658.6 275.7 (2.6)% (8.7) (18.4) (6.7)% (22.7) (23.3) (3.4)% (3.3)% Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 The segment’s performance was impacted by challenging feedstock conditions, higher manufacturing costs and lower ethanol tender allotments resulting in shrinkage in the margins for the first half of FY27. Godavari Biorefineries Limited 6 Revenue Mix QUARTERLY HALF YEARLY 2% 2% 2% 2% 34% 34% Rs. 430.8 Cr Rs. 549.2 Cr Rs. 964.0 Cr Rs. 1107.1 Cr Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 64% 64% Integrated Sugar, Co-generation and Ethanol Bio-Based Chemicals Unallocated Godavari Biorefineries Limited 7 Consolidated P&L Statement Particulars (in INR Crs) Q2 FY27 Q2 FY26 Y-o-Y Q1 FY27 Q-o-Q H1 FY27 H1 FY26 Y-o-Y Revenue from Operations 549.2 430.8 557.9 1107.1 964.0 Other Income 0.5 3.5 2.0 2.6 4.3 Total Income 549.8 434.3 26.6% 559.9 (1.8)% 1,109.7 968.2 14.6% Cost of Materials Consumed 220.4 146.2 185.5 405.9 351.7 Purchase of Finished Goods 10.6 9.5 10.4 21.0 17.8 Changes in Inventories of Finished Goods and WIP 198.7 187.2 263.2 462.0 404.9 Gross Profit 120.0 91.4 31.3% 100.9 19.0% 220.8 193.8 14.0% GP % 21.8% 21.0% 18.0% 19.9% 20.0% Employee Benefits Expense 36.6 31.5 33.0 69.6 63.7 Other Expenses 72.5 64.2 65.3 137.8 128.0 EBITDA* 10.9 (4.4) 2.6 322.3% 13.4 2.1 542.6% EBITDA % 2.0% (1.0)% 0.5% 1.2% 0.2% Depreciation and Amortisation Expense 15.2 13.5 14.5 29.7 27.0 EBIT (4.4) (17.9) (75.7)% (11.9) (63.5)% (16.3) (24.9) (34.7)% Finance Costs 15.4 12.3 13.9 29.3 27.6 Profit before exceptional expense (19.7) (30.2) (34.7)% (25.8) (23.6)% (45.6) (52.5) (13.2)% Exceptional Expenses 0.0 26.7 0.0 0.0 26.7 Profit/(Loss) before tax for the period (19.7) (56.9) (65.3)% (25.8) (23.6)% (45.6) (79.2) (42.4)% Tax Expense (4.5) (15.3) (6.5) (11.0) (21.6) Profit/(Loss) after Tax (15.2) (41.6) (63.4)% (19.3) (21.1)% (34.6) (57.6) (40.0)% Godavari Biorefineries Limited 8 Consolidated Balance Sheet Particulars (in INR Cr) Sep 26 Mar 26 Particulars (in INR Cr) Sep 26 Mar 26 ASSETS EQUITY AND LIABILITIES Non-current assets EQUITY (i) Equity share capital 51.2 51.2 (a) Property, plant and equipment 959.7 864.1 (ii) Other equity 701.9 737.1 (b) Capital Work-in-Progress 0.5 0.7 Total Equity 753.1 788.3 (c) Right to use Asset 55.4 129.3 LIABILITIES (d) Intangible Asset 1.3 1.2 Non-current liabilities (e) Intangible Assets Under Development 21.1 18.6 (i) Financial Liabilities (f) Investment accounted for equity method 0.0 0.0 -Borrowings 324.4 333.3 (g) Financial Assets -Lease Liabilities 0.4 0.5 (i) Investments 0.1 0.1 -Other financial liabilities 9.8 9.5 (ii) Trade Receivables 0.4 0.5 (ii) Provisions 3.3 3.0 (iii) Other financial assets 17.2 19.0 (iii) Deferred tax Liabilities 31.1 42.9 (h) Other Non-current assets 27.6 27.3 (iv) Other Non-Current Liabilities 0.4 0.4 Total non-current assets 1083.4 1060.7 Total Non-Current Liabilit [Showing first 8,000 characters — download PDF for full document]